Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Intracranial Injection of Investigational Ex Vivo Expanded and Activated Gamma-Delta T Cells Engineered With a Methylguanine-DNA Methyltransferase-Expressing Lentivector in Patients With Primary Glioblastoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 08, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.
Journal: Research square
Published: July 03, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.
Journal: Research square
Published: July 03, 2026
TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 01, 2026
TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Depot Medroxyprogesterone Acetate and Risk of Meningioma in the US.
Journal: JAMA neurology
Published: September 02, 2025
Expedited chemoradiation after laser interstitial thermal therapy (LITT) is feasible and safe in patients with newly diagnosed glioblastoma.
Journal: Neuro-oncology advances
Published: April 25, 2025
Intracerebral hemorrhage risk in glioma patients taking direct oral anticoagulants as compared with low molecular weight heparin.
Journal: Neuro-oncology advances
Published: March 27, 2025
Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial.
Journal: JAMA dermatology
Published: February 26, 2025
Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results.
Journal: Nature cancer
Published: November 21, 2024
Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS Lymphoma.
Journal: JCO oncology practice
Published: June 25, 2024
Last Updated: 09/26/2026